Cytotoxic effects of curcumin on osteosarcoma cell lines Denise K. WaltersRoman MuffBruno Fuchs PRECLINICAL STUDIES 11 December 2007 Pages: 289 - 297
Identification of small molecules inducing apoptosis by cell-based assay using fission yeast deletion mutants Kyung-Sook ChungNam-Hui YimMisun Won PRECLINICAL STUDIES 19 January 2008 Pages: 299 - 307
The combination of gamma ionizing radiation and 8-Cl-cAMP induces synergistic cell growth inhibition and induction of apoptosis in human prostate cancer cells Vesna VučićAna NićiforovićSabera Ruždijić PRECLINICAL STUDIES 04 December 2007 Pages: 309 - 317
Murine leukemia P388 vinorelbine-resistant cell lines are sensitive to vinflunine Ashish AggarwalAnna KruczynskiSharon Lobert PRECLINICAL STUDIES 11 December 2007 Pages: 319 - 330
A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia Wendy StockSamir D. UndeviaFrancis J. Giles PHASE I STUDIES 19 April 2008 Pages: 331 - 338
Phase I trial of pemetrexed plus oxaliplatin administered every other week in patients with metastatic cancer Daniel G. StoverA. Craig LockhartMace L. Rothenberg PHASE I STUDIES 08 May 2008 Pages: 339 - 345
Phase I dose-escalation study of the thioxanthone SR271425 administered intravenously once every 3 weeks in patients with advanced malignancies Priscila H. GoncalvesFrancine HighPatricia M. LoRusso PHASE I STUDIES 01 May 2008 Pages: 347 - 354
Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principles Sharon L. SanbornMatthew M. CooneyScot C. Remick PHASE I STUDIES 10 May 2008 Pages: 355 - 362
Biweekly administration of gemcitabine and cisplatin chemotherapy in patients with anthracycline and taxane-pretreated metastatic breast cancer Faruk TasNese GuneyErkan Topuz PHASE II STUDIES 29 December 2007 Pages: 363 - 368
A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas Steven AttiaJill KolesarKyle D. Holen PHASE II STUDIES 16 February 2008 Pages: 369 - 379
A phase II study of pemetrexed in patients with advanced hepatocellular carcinoma Allen L. CohnJ. William MyersLina Asmar PHASE II STUDIES 28 February 2008 Pages: 381 - 386
Salvage chemotherapy with mitomycin C, ifosfamide, and cisplatin (MIC) for previously treated metastatic or recurrent esophageal squamous cell carcinoma Byeong-Bae ParkYoung-Hyuck ImKeunchil Park PHASE II STUDIES 27 March 2008 Pages: 387 - 392
Gastrointestinal ulceration as a possible side effect of bevacizumab which may herald perforation J. TolA. CatsC. J. A. Punt PHASE III STUDIES Open access 12 March 2008 Pages: 393 - 397